Last Updated: May 15, 2025

‍

Tirzepatide Disclaimer
This compounded medication contains Tirzepatide combined with glycine and vitamin B12, and is formulated specifically for individual patients who may not tolerate standard formulations or who require a customized therapeutic approach. It is prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act and is dispensed solely pursuant to a valid patient-specific prescription from a licensed healthcare provider.

Our compounded formulation is not affiliated with, endorsed by, or intended to replace the FDA-approved product manufactured by Eli Lilly.

The addition of glycine and vitamin B12 is intended to support patients experiencing issues such as fatigue, muscle loss, or neuropathy—common concerns during weight loss or diabetes treatment—and may offer metabolic, neurological, and musculoskeletal benefits.
This medication is not made for resale, bulk distribution, or office use, and is compounded exclusively to meet the clinical needs of individual patients when commercially available alternatives are not appropriate.

Purpose

Tirzepatide+ with B6 is our leading dual-acting GLP-1/GIP therapy—enhanced with B6 for better tolerability and neurological support. With powerful appetite-suppressing effects and a multifaceted approach to metabolic health, this formulation may help you achieve significant weight loss while improving blood sugar control. Patients commonly report improved energy and fewer side effects.

• Vitamin B6 helps reduce nausea associated with GLP-1 therapy and supports nerve function.

• Tirzepatide acts on both GLP-1 and GIP receptors to regulate insulin, suppress appetite, and slow gastric emptying, with potential cardiovascular and metabolic benefits.

‍

Semaglutide Disclaimer

This compounded medication contains Semaglutide combined with vitamin B12, designed for individual patients requiring customized care due to tolerance issues or specific therapeutic needs. It is prepared according to Section 503A of the Federal Food, Drug, and Cosmetic Act and dispensed only under a valid, patient-specific prescription.

This formulation is not associated with or endorsed by the makers of the FDA-approved Ozempic or Wegovy products. Vitamin B12 is added to help reduce nausea, replenish common deficiencies seen in weight loss patients, and support energy and neurological health during treatment.

This medication is not for resale, office use, or mass distribution. It is compounded exclusively to meet the unique medical needs of each patient.

Purpose

Semaglutide+ with B12 is an advanced formulation of the widely used GLP-1 receptor agonist, designed to enhance tolerability and overall wellness during your weight loss journey.

• Vitamin B12 helps minimize nausea, a common side effect, and supports energy production and nerve health—especially important during caloric restriction and rapid weight loss.

(Healthline Reference: GLP-1 Nutrient Deficiency Risks)

• Semaglutide mimics the GLP-1 hormone to regulate insulin release, suppress appetite, and slow digestion, resulting in improved glycemic control and sustainable weight loss.

‍

‍

‍

‍

‍

‍

‍

‍

‍

‍

‍